The 26 references in paper , статья Редакционная (2016) “ИНТЕРСТИЦИАЛЬНАЯ ПНЕВМОНИЯ С АУТОИММУННЫМИ ПРОЯВЛЕНИЯМИ: СОВМЕСТНЫЙ КОНСЕНСУС ЕВРОПЕЙСКОГО РЕСПИРАТОРНОГО И АМЕРИКАНСКОГО ТОРАКАЛЬНОГО ОБЩЕСТВ // INTERSTITIAL PNEUMONIAE WITH AUTOIMMUNE MANIFESTATIONS. JOINT CONSENSUS OF THE ERS/ATS” / spz:neicon:pulmonology:y:2016:i:5:p:529-538

1
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am. J. Respir. Crit. Care Med.2002; 165: 277–304.
(check this in PDF content)
2
Raghu G., Collard H.R., Egan J.J. et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.Am. J. Respir. Crit. Care Med. 2011; 183: 788–824.
(check this in PDF content)
3
Travis W.D., Costabel U., Hansell D.M. et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013; 188: 733–748.
(check this in PDF content)
4
Park J.H., Kim D.S., Park I.N. et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes.Am. J. Respir. Crit. Care Med. 2007; 175: 705–711.
(check this in PDF content)
5
Solomon J.J., Chartrand S., Fischer A. Current approach to connective tissue disease-associated interstitial lung disease. Curr. Opin. Pulm. Med.2014; 20: 449–456.
(check this in PDF content)
6
Vij R., Strek M.E. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest. 2013; 143: 814–824.
(check this in PDF content)
7
Fischer A., du Bois R. Interstitial lung disease in connective tissue disorders. Lancet. 2012; 380: 689–698.
(check this in PDF content)
8
Tzelepis G.E., Toya S.P., Moutsopoulos H.M. Occult connective tissue diseases mimicking idiopathic interstitial pneumonias.Eur. Respir. J. 2008; 31: 11–20.
(check this in PDF content)
9
Mittoo S., Gelber A.C., Christopher-Stine L. et al. Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease. Respir. Med.2009; 103: 1152–1158.
(check this in PDF content)
10
Castelino F.V., Varga J. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res. Ther. 2010; 12: 213.
(check this in PDF content)
11
Castelino F.V., Goldberg H., Dellaripa P.F. The impact of rheumatological evaluation in the management of patients with interstitial lung disease.Rheumatology(Oxford). 2011; 50: 489–493.
(check this in PDF content)
12
Cottin V. Interstitial lung disease: are we missing formes frustes of connective tissue disease? Eur. Respir. J. 2006; 28: 893–896.
(check this in PDF content)
13
Fischer A., Meehan R.T., Feghali-Bostwick C.A. et al. Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease. Chest. 2006; 130: 976–981.
(check this in PDF content)
14
Fischer A., Pfalzgraf F.J., Feghali-Bostwick C.A. et al. Antith/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis. J. Rheumatol.2006; 33: 1600–1605.
(check this in PDF content)
15
Fischer A., Swigris J.J., du Bois R.M. et al. Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease. Chest. 2009; 136: 1072–1078.
(check this in PDF content)
16
Fischer A., Swigris J.J., du Bois R.M. et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir. Med. 2009; 103: 1719–1724.
(check this in PDF content)
17
Cottin V. Interstitial lung disease.Eur. Respir. Rev. 2013; 22: 26–32.
(check this in PDF content)
18
Fischer A., Richeldi L. Cross-disciplinary collaboration in connective tissue disease-related lung disease. Semin. Respir. Crit. Care Med.2014; 35: 159–165.
(check this in PDF content)
19
Kinder B.W., Collard H.R., Koth L. et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am. J. Respir. Crit. Care Med. 2007; 176: 691–697.
(check this in PDF content)
20
Fischer A., West S.G., Swigris J.J. et al. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest.2010; 138: 251–256.
(check this in PDF content)
21
Vij R., Noth I., Strek M.E. Autoimmune-featured interstitial lung disease: a distinct entity. Chest. 2011; 140: 1292–1299.
(check this in PDF content)
22
Corte T.J., Copley S.J., Desai S.R. et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur. Respir. J.2012; 39: 661–668.
(check this in PDF content)
23
LeRoy E.C., Black C., Fleischmajer R. et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol.1988; 15: 202–205.
(check this in PDF content)
24
LeRoy E.C., Medsger T.A. Jr. Criteria for the classification of early systemic sclerosis. J. Rheumatol.2001; 28: 1573–1576.
(check this in PDF content)
25
Hervier B., Wallaert B., Hachulla E. et al. Clinical manifestations of anti-synthetase syndrome positive for anti-alanyltRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases. Rheumatology(Oxford). 2010; 49: 972–976.
(check this in PDF content)
26
Kalluri M., Sahn S.A., Oddis C.V. et al. Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the
(check this in PDF content)